Drug · DIN 02018144
CYCLOMEN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 12, 2025; first marketed December 31, 1980.
- Drug Identification Number (DIN)
- 02018144
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Danazol G03XA01
- Class
- Human
- Record last updated
- August 21, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DANAZOL | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 18, 2006: NOC 7883New Drug Submission (NDS) · Manufacturer name change
- October 24, 2000: NOC 1085New Drug Submission (NDS)
Other DINs named CYCLOMEN
- DIN 02018152 · Marketed
- DIN 02018160 · Marketed